Access and care for people with opioid use disorder in U.S. skilled nursing facilities: A policy commentary

IF 4.4 2区 医学 Q1 SUBSTANCE ABUSE International Journal of Drug Policy Pub Date : 2024-10-08 DOI:10.1016/j.drugpo.2024.104607
Shivani Nishar , Jon Soske , Rahul Vanjani , Simeon D. Kimmel , Corinne Roma , Patience M. Dow
{"title":"Access and care for people with opioid use disorder in U.S. skilled nursing facilities: A policy commentary","authors":"Shivani Nishar ,&nbsp;Jon Soske ,&nbsp;Rahul Vanjani ,&nbsp;Simeon D. Kimmel ,&nbsp;Corinne Roma ,&nbsp;Patience M. Dow","doi":"10.1016/j.drugpo.2024.104607","DOIUrl":null,"url":null,"abstract":"<div><div>Referrals for people with opioid use disorder (OUD) to skilled nursing facilities (SNFs) are increasing in the United States (U.S.). Further, legal guidance from the U.S. Department of Justice states that people with OUD cannot be discriminated against by health care institutions because of OUD or treatment with medications for OUD (MOUD). As such, SNFs are an important touchpoint for initiating or continuing MOUD, particularly amid rising drug-related overdose deaths among older adults and because people with OUD experience frailty and other geriatric syndromes at younger chronological ages. Informed by research, clinical expertise, and lived experience, this commentary describes policy and practice opportunities to help address challenges faced by people with OUD in gaining access to care and MOUD in SNFs. We propose opportunities to intervene against barriers that impede SNF placement and access to MOUD for people with OUD, including further revisions to 42 CFR Part 8 regulations to extend waivers for certification as opioid treatment programs (OTPs) to SNFs, allowing them to administer and dispense methadone in the same way as hospitals. If passed, proposed federal changes under the Modernizing Opioid Treatment Act would eliminate the requirement for methadone to be dispensed through OTPs, offering another opportunity to improve access to methadone for SNF residents. Also, we propose national and state-level investment in mobile substance use disorder services and partnerships with OTPs and hospital-based addiction consult services. We also recognize the need for more compassionate attitudes toward people with OUD in healthcare settings and discuss opportunities to address stigma. Although people with OUD are referred to SNFs for skilled care needs and not specifically for OUD care, it is essential for SNFs to be prepared to continue MOUD. It is both legally mandated and imperative that people with OUD have access to high quality and equitable SNF care.</div></div>","PeriodicalId":48364,"journal":{"name":"International Journal of Drug Policy","volume":"133 ","pages":"Article 104607"},"PeriodicalIF":4.4000,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Drug Policy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0955395924002913","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

Abstract

Referrals for people with opioid use disorder (OUD) to skilled nursing facilities (SNFs) are increasing in the United States (U.S.). Further, legal guidance from the U.S. Department of Justice states that people with OUD cannot be discriminated against by health care institutions because of OUD or treatment with medications for OUD (MOUD). As such, SNFs are an important touchpoint for initiating or continuing MOUD, particularly amid rising drug-related overdose deaths among older adults and because people with OUD experience frailty and other geriatric syndromes at younger chronological ages. Informed by research, clinical expertise, and lived experience, this commentary describes policy and practice opportunities to help address challenges faced by people with OUD in gaining access to care and MOUD in SNFs. We propose opportunities to intervene against barriers that impede SNF placement and access to MOUD for people with OUD, including further revisions to 42 CFR Part 8 regulations to extend waivers for certification as opioid treatment programs (OTPs) to SNFs, allowing them to administer and dispense methadone in the same way as hospitals. If passed, proposed federal changes under the Modernizing Opioid Treatment Act would eliminate the requirement for methadone to be dispensed through OTPs, offering another opportunity to improve access to methadone for SNF residents. Also, we propose national and state-level investment in mobile substance use disorder services and partnerships with OTPs and hospital-based addiction consult services. We also recognize the need for more compassionate attitudes toward people with OUD in healthcare settings and discuss opportunities to address stigma. Although people with OUD are referred to SNFs for skilled care needs and not specifically for OUD care, it is essential for SNFs to be prepared to continue MOUD. It is both legally mandated and imperative that people with OUD have access to high quality and equitable SNF care.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
美国专业护理机构对阿片类药物使用障碍患者的访问和护理:政策评论。
在美国,将阿片类药物使用失调症(OUD)患者转介到专业护理机构(SNFs)的情况越来越多。此外,美国司法部的法律指南规定,医疗机构不得因阿片类药物使用障碍或阿片类药物使用障碍药物治疗(MOUD)而歧视阿片类药物使用障碍患者。因此,SNF 是开始或继续 MOUD 治疗的重要接触点,尤其是在老年人中与药物过量相关的死亡人数不断上升的情况下,而且由于 OUD 患者在较年轻时就会出现虚弱和其他老年综合症。本评论以研究、临床专业知识和生活经验为基础,描述了政策和实践机会,以帮助解决 OUD 患者在获得护理和 SNF 中的 MOUD 方面所面临的挑战。我们提出了一些机会来干预那些阻碍 SNF 安置和 OUD 患者获得 MOUD 的障碍,包括进一步修订 42 CFR 第 8 部分的规定,将阿片类药物治疗计划 (OTP) 认证的豁免权扩展至 SNF,允许它们以与医院相同的方式管理和分配美沙酮。如果《阿片类药物治疗现代化法案》(Modernizing Opioid Treatment Act)中的联邦修改提案获得通过,将取消美沙酮必须通过 OTPs 配发的要求,从而为改善 SNF 居民获得美沙酮的机会提供另一个契机。此外,我们还建议在国家和州一级对流动药物使用障碍服务进行投资,并与 OTP 和医院成瘾咨询服务建立合作关系。我们还认识到在医疗机构中需要对 OUD 患者采取更富有同情心的态度,并讨论了解决污名化问题的机会。虽然 OUD 患者被转介到 SNFs 是为了满足专业护理需求,而不是专门为了 OUD 护理,但 SNFs 必须做好继续开展 MOUD 的准备。让 OUD 患者获得优质、公平的 SNF 护理既是法律规定,也是当务之急。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.80
自引率
11.40%
发文量
307
审稿时长
62 days
期刊介绍: The International Journal of Drug Policy provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug-using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world.
期刊最新文献
National impact of a constraining regulatory framework on pregabalin dispensations in France, 2020–2022 Suboptimal uptake and placement of a mandatory alcohol pregnancy warning label in Australia Increases in employment over six months following Khanya: A secondary analysis of a pilot randomized controlled trial of a peer-delivered behavioral intervention for substance use and HIV medication adherence in Cape Town, South Africa The criminal careers of Australian drug traffickers Impact of the COVID-19 pandemic on cannabis cultivation and use in 18 countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1